An open-label study to evaluate the single-dose pharmacokinetics and safety of ceftobiprole in neonate and infant subjects aged up to 3 months undergoing treatment with systemic antibiotics

Administered By

Awarded By

Contributors

Start/End

  • November 28, 2018 - August 27, 2021